Abstract
The previous demonstration of the efficacy and tolerability of the Oka strain of varicella-zoster virus (VZV) in clinical trials involving vaccination of both normal and immunocompromised individuals has laid the foundation for its use in preventing chickenpox. In this context, VZV could be useful as a vector for vaccinating against other infectious agents as well. As an initial application, a live recombinant VZV expressing Epstein-Barr virus (EBV) membrane glycoproteins (gp350/220) was generated by inserting a gene fusion of the VZV gpI promoter and hydrophobic leader-encoding sequence with the gp350/220 coding sequence into the thymidine kinase (TK) gene of VZV (Oka). Insertion of the foreign DNA into the thymidine kinase gene was demonstrated by Southern blot analysis and the ability of the recombinant virus to replicate in the presence of bromodeoxyuridine. RNA splicing, glycosylation, and plasma membrane presentation of gp350/220 in cells infected with the recombinant virus were similar to those seen in EBV-infected cells. In addition, the expression of VZV-specific glycoproteins was unaltered by the concomitant expression of this large foreign glycoprotein. Thus, VZV can be used as a live viral vector for active immunization against EBV and other pathogens.
Full text
PDF![3896](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ff/304983/fc9c23a8889d/pnas00276-0367.png)
![3897](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ff/304983/5eb95a686165/pnas00276-0368.png)
![3898](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ff/304983/30553e233d75/pnas00276-0369.png)
![3899](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ff/304983/3105a9910f49/pnas00276-0370.png)
![3900](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ff/304983/6e9140e9af84/pnas00276-0371.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander S., Elder J. H. Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science. 1984 Dec 14;226(4680):1328–1330. doi: 10.1126/science.6505693. [DOI] [PubMed] [Google Scholar]
- Almeida J. D., Edwards D. C., Brand C. M., Heath T. D. Formation of virosomes from influenza subunits and liposomes. Lancet. 1975 Nov 8;2(7941):899–901. doi: 10.1016/s0140-6736(75)92130-3. [DOI] [PubMed] [Google Scholar]
- Atkinson K., Meyers J. D., Storb R., Prentice R. L., Thomas E. D. Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation. 1980;29(1):47–50. doi: 10.1097/00007890-198001000-00010. [DOI] [PubMed] [Google Scholar]
- Beisel C., Tanner J., Matsuo T., Thorley-Lawson D., Kezdy F., Kieff E. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J Virol. 1985 Jun;54(3):665–674. doi: 10.1128/jvi.54.3.665-674.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown J. P., Twardzik D. R., Marquardt H., Todaro G. J. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature. 1985 Feb 7;313(6002):491–492. doi: 10.1038/313491a0. [DOI] [PubMed] [Google Scholar]
- Brunell P. A., Taylor-Wiedeman J., Geiser C. F., Frierson L., Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 1986 Jan;77(1):53–56. [PubMed] [Google Scholar]
- Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
- Clifford P. A review on the epidemiology of nasopharyngeal carcinoma. Int J Cancer. 1970 May 15;5(3):287–309. doi: 10.1002/ijc.2910050302. [DOI] [PubMed] [Google Scholar]
- Davison A. J., Scott J. E. Molecular cloning of the varicella-zoster virus genome and derivation of six restriction endonuclease maps. J Gen Virol. 1983 Aug;64(Pt 8):1811–1814. doi: 10.1099/0022-1317-64-8-1811. [DOI] [PubMed] [Google Scholar]
- Davison A. J., Scott J. E. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 1986 Sep;67(Pt 9):1759–1816. doi: 10.1099/0022-1317-67-9-1759. [DOI] [PubMed] [Google Scholar]
- Edson C. M., Thorley-Lawson D. A. Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus. J Virol. 1983 May;46(2):547–556. doi: 10.1128/jvi.46.2.547-556.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis R. W., Keller P. M., Lowe R. S., Zivin R. A. Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC. J Virol. 1985 Jan;53(1):81–88. doi: 10.1128/jvi.53.1.81-88.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eppstein D. A., Marsh Y. V., Schreiber A. B., Newman S. R., Todaro G. J., Nestor J. J., Jr Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature. 1985 Dec 19;318(6047):663–665. doi: 10.1038/318663a0. [DOI] [PubMed] [Google Scholar]
- Epstein M. A. Epstein-Barr virus--is it time to develop a vaccine program? J Natl Cancer Inst. 1976 Apr;56(4):697–700. doi: 10.1093/jnci/56.4.697. [DOI] [PubMed] [Google Scholar]
- Epstein M. A. The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours. Proc R Soc Lond B Biol Sci. 1984 Mar 22;221(1222):1–20. doi: 10.1098/rspb.1984.0019. [DOI] [PubMed] [Google Scholar]
- Feldman S., Hughes W. T., Kim H. Y. Herpes zoster in children with cancer. Am J Dis Child. 1973 Aug;126(2):178–184. doi: 10.1001/archpedi.1973.02110190156009. [DOI] [PubMed] [Google Scholar]
- Gershon A. A., Steinberg S. P., Gelb L., Galasso G., Borkowsky W., LaRussa P., Farrara A. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA. 1984 Jul 20;252(3):355–362. doi: 10.1001/jama.252.3.355. [DOI] [PubMed] [Google Scholar]
- Hanngren K., Grandien M., Granström G. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis. 1985;17(4):343–347. doi: 10.3109/13813458509058773. [DOI] [PubMed] [Google Scholar]
- Hoffman G. J., Lazarowitz S. G., Hayward S. D. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc Natl Acad Sci U S A. 1980 May;77(5):2979–2983. doi: 10.1073/pnas.77.5.2979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jacobs J. P., Jones C. M., Baille J. P. Characteristics of a human diploid cell designated MRC-5. Nature. 1970 Jul 11;227(5254):168–170. doi: 10.1038/227168a0. [DOI] [PubMed] [Google Scholar]
- KEMPE C. H. Studies smallpox and complications of smallpox vaccination. Pediatrics. 1960 Aug;26:176–189. [PubMed] [Google Scholar]
- Keller P. M., Davison A. J., Lowe R. S., Bennett C. D., Ellis R. W. Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology. 1986 Jul 15;152(1):181–191. doi: 10.1016/0042-6822(86)90383-1. [DOI] [PubMed] [Google Scholar]
- Keller P. M., Davison A. J., Lowe R. S., Riemen M. W., Ellis R. W. Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology. 1987 Apr;157(2):526–533. doi: 10.1016/0042-6822(87)90295-9. [DOI] [PubMed] [Google Scholar]
- Keller P. M., Neff B. J., Ellis R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol. 1984 Oct;52(1):293–297. doi: 10.1128/jvi.52.1.293-297.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Littman D. R., Thomas Y., Maddon P. J., Chess L., Axel R. The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell. 1985 Feb;40(2):237–246. doi: 10.1016/0092-8674(85)90138-2. [DOI] [PubMed] [Google Scholar]
- Lowy D. R., Rands E., Scolnick E. M. Helper-independent transformation by unintegrated Harvey sarcoma virus DNA. J Virol. 1978 May;26(2):291–298. doi: 10.1128/jvi.26.2.291-298.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mackett M., Arrand J. R. Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. EMBO J. 1985 Dec 1;4(12):3229–3234. doi: 10.1002/j.1460-2075.1985.tb04070.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mackett M., Smith G. L., Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415–7419. doi: 10.1073/pnas.79.23.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manesis E. K., Cameron C. H., Gregoriadis G. Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett. 1979 Jun 1;102(1):107–111. doi: 10.1016/0014-5793(79)80939-4. [DOI] [PubMed] [Google Scholar]
- Masucci M. G., Szigeti R., Ernberg I., Björkholm M., Mellstedt H., Henle G., Henle W., Pearson G., Masucci G., Svedmyr E. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers. Cancer Res. 1981 Nov;41(11 Pt 1):4292–4301. [PubMed] [Google Scholar]
- Panicali D., Paoletti E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci U S A. 1982 Aug;79(16):4927–4931. doi: 10.1073/pnas.79.16.4927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paryani S. G., Arvin A. M. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 1986 Jun 12;314(24):1542–1546. doi: 10.1056/NEJM198606123142403. [DOI] [PubMed] [Google Scholar]
- Plotkin S. A., Arbetter A. A., Starr S. E. The future of varicella vaccine. Postgrad Med J. 1985;61 (Suppl 4):155–162. [PubMed] [Google Scholar]
- Purtilo D. T., Sakamoto K., Saemundsen A. K., Sullivan J. L., Synnerholm A. C., Anvret M., Pritchard J., Sloper C., Sieff C., Pincott J. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res. 1981 Nov;41(11 Pt 1):4226–4236. [PubMed] [Google Scholar]
- Ruckdeschel J. C., Schimpff S. C., Smyth A. C., Mardiney M. R., Jr Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease. Am J Med. 1977 Jan;62(1):77–85. doi: 10.1016/0002-9343(77)90352-7. [DOI] [PubMed] [Google Scholar]
- Sakai F., Gerlier D., Doré J. F. Association of gross virus-associated cell-surface antigen with liposomes. Br J Cancer. 1980 Feb;41(2):227–235. doi: 10.1038/bjc.1980.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sawyer M. H., Ostrove J. M., Felser J. M., Straus S. E. Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript. Virology. 1986 Feb;149(1):1–9. doi: 10.1016/0042-6822(86)90081-4. [DOI] [PubMed] [Google Scholar]
- Shih M. F., Arsenakis M., Tiollais P., Roizman B. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5867–5870. doi: 10.1073/pnas.81.18.5867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slot J. W., Geuze H. J. A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol. 1985 Jul;38(1):87–93. [PubMed] [Google Scholar]
- Souhami R. L., Babbage J., Sigfusson A. Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease. Clin Exp Immunol. 1983 Aug;53(2):297–307. [PMC free article] [PubMed] [Google Scholar]
- Straus S. E., Aulakh H. S., Ruyechan W. T., Hay J., Casey T. A., Vande Woude G. F., Owens J., Smith H. A. Structure of varicella-zoster virus DNA. J Virol. 1981 Nov;40(2):516–525. doi: 10.1128/jvi.40.2.516-525.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strnad B. C., Schuster T., Klein R., Hopkins R. F., 3rd, Witmer T., Neubauer R. H., Rabin H. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J Virol. 1982 Jan;41(1):258–264. doi: 10.1128/jvi.41.1.258-264.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takahashi M. Chickenpox virus. Adv Virus Res. 1983;28:285–356. doi: 10.1016/s0065-3527(08)60726-5. [DOI] [PubMed] [Google Scholar]
- Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974 Nov 30;2(7892):1288–1290. doi: 10.1016/s0140-6736(74)90144-5. [DOI] [PubMed] [Google Scholar]
- Thorley-Lawson D. A., Geilinger K. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5307–5311. doi: 10.1073/pnas.77.9.5307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thorley-Lawson D. A., Poodry C. A. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol. 1982 Aug;43(2):730–736. doi: 10.1128/jvi.43.2.730-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weibel R. E., Neff B. J., Kuter B. J., Guess H. A., Rothenberger C. A., Fitzgerald A. J., Connor K. A., McLean A. A., Hilleman M. R., Buynak E. B. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984 May 31;310(22):1409–1415. doi: 10.1056/NEJM198405313102201. [DOI] [PubMed] [Google Scholar]
- Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(5450):701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]